1
|
Developmental and spatial patterns of expression of the mouse homeobox gene, Hox 2.1.
|
Development
|
1987
|
2.44
|
2
|
Characterization of a murine homeo box gene, Hox-2.6, related to the Drosophila Deformed gene.
|
Genes Dev
|
1988
|
1.75
|
3
|
In vivo expression of mRNA for the Ca++-binding protein SPARC (osteonectin) revealed by in situ hybridization.
|
J Cell Biol
|
1987
|
1.70
|
4
|
High-grade stereo acuity after early surgery for congenital esotropia.
|
Arch Ophthalmol
|
1994
|
1.44
|
5
|
Postinjury vascular intimal hyperplasia in mice is completely inhibited by CD34+ bone marrow-derived progenitor cells expressing membrane-tethered anticoagulant fusion proteins.
|
J Thromb Haemost
|
2006
|
1.41
|
6
|
Expression of the human calcitonin/CGRP gene in lung and thyroid carcinoma.
|
EMBO J
|
1985
|
1.39
|
7
|
The regulation of tissue factor mRNA in human endothelial cells in response to endotoxin or phorbol ester.
|
J Biol Chem
|
1990
|
1.28
|
8
|
450 million years of hemostasis.
|
J Thromb Haemost
|
2003
|
1.22
|
9
|
Temporal expression of alternatively spliced forms of tissue factor pathway inhibitor in mice.
|
J Thromb Haemost
|
2009
|
1.20
|
10
|
A cDNA clone encoding the mouse Qa-1a histocompatibility antigen and proposed structure of the putative peptide binding site.
|
J Immunol
|
1993
|
1.16
|
11
|
Haemophilia A diagnosis by analysis of a hypervariable dinucleotide repeat within the factor VIII gene.
|
Lancet
|
1991
|
1.11
|
12
|
High-level production of human blood coagulation factors VII and XI using a new mammalian expression vector.
|
Gene
|
1994
|
1.09
|
13
|
Differential regulation by cytokines of constitutive and stimulated secretion of von Willebrand factor from endothelial cells.
|
Blood
|
1990
|
1.05
|
14
|
The molecular genetic analysis of hemophilia A: a directed search strategy for the detection of point mutations in the human factor VIII gene.
|
Blood
|
1990
|
1.03
|
15
|
Molecular analysis of the ERGIC-53 gene in 35 families with combined factor V-factor VIII deficiency.
|
Blood
|
1999
|
1.00
|
16
|
Fluid shear stress induction of the tissue factor promoter in vitro and in vivo is mediated by Egr-1.
|
Arterioscler Thromb Vasc Biol
|
1999
|
0.99
|
17
|
Surface plasmon resonance studies of the interaction between factor VII and tissue factor. Demonstration of defective tissue factor binding in a variant FVII molecule (FVII-R79Q).
|
Biochemistry
|
1994
|
0.98
|
18
|
Factor Xa and thrombin, but not factor VIIa, elicit specific cellular responses in dermal fibroblasts.
|
J Thromb Haemost
|
2003
|
0.95
|
19
|
Evidence for positive and negative regulatory elements in the 5'-flanking sequence of the mouse sparc (osteonectin) gene.
|
J Biol Chem
|
1989
|
0.94
|
20
|
Efficient gene transfer into human umbilical vein endothelial cells allows functional analysis of the human tissue factor gene promoter.
|
Br J Haematol
|
1994
|
0.88
|
21
|
Domains of invasion organelle proteins from apicomplexan parasites are homologous with the Apple domains of blood coagulation factor XI and plasma pre-kallikrein and are members of the PAN module superfamily.
|
FEBS Lett
|
2001
|
0.87
|
22
|
The interface between coagulation and immunity.
|
Am J Transplant
|
2007
|
0.87
|
23
|
Analysis of the F8 gene in individuals with high plasma factor VIII: C levels and associated venous thrombosis.
|
Thromb Haemost
|
1998
|
0.87
|
24
|
Nomenclature of genetic variants in hemostasis.
|
J Thromb Haemost
|
2011
|
0.86
|
25
|
Differential expression of the human calcitonin--CGRP gene in medullary thyroid carcinoma and lung carcinoma cell lines.
|
Recent Results Cancer Res
|
1985
|
0.85
|
26
|
In utero administration of Ad5 and AAV pseudotypes to the fetal brain leads to efficient, widespread and long-term gene expression.
|
Gene Ther
|
2011
|
0.85
|
27
|
Inhibition of tissue factor-dependent and -independent coagulation by cell surface expression of novel anticoagulant fusion proteins.
|
Transplantation
|
1999
|
0.84
|
28
|
Regulated inhibition of coagulation by porcine endothelial cells expressing P-selectin-tagged hirudin and tissue factor pathway inhibitor fusion proteins.
|
Transplantation
|
1999
|
0.84
|
29
|
Haemophilia A diagnosis by simultaneous analysis of two variable dinucleotide tandem repeats within the factor VIII gene.
|
Br J Haematol
|
1994
|
0.84
|
30
|
Purification and characterization of factor VII 304-Gln: a variant molecule with reduced activity isolated from a clinically unaffected male.
|
Blood
|
1991
|
0.83
|
31
|
Detection and characterisation of two missense mutations at a cleavage site in the factor VIII light chain.
|
Thromb Res
|
1991
|
0.83
|
32
|
CRM+ haemophilia A due to a missense mutation (372----Cys) at the internal heavy chain thrombin cleavage site.
|
Br J Haematol
|
1990
|
0.83
|
33
|
Molecular analysis of the genotype-phenotype relationship in factor VII deficiency.
|
Hum Genet
|
2000
|
0.83
|
34
|
The chromatin structure of the mouse beta-2-microglobulin locus.
|
Differentiation
|
1992
|
0.82
|
35
|
Factor V I359T: a novel mutation associated with thrombosis and resistance to activated protein C.
|
Br J Haematol
|
2003
|
0.81
|
36
|
Human tissue factor pathway inhibitor fused to CD4 binds both FXa and TF/FVIIa at the cell surface.
|
Thromb Haemost
|
1997
|
0.80
|
37
|
The genetic basis of inhibitor development in haemophilia A.
|
Haemophilia
|
1998
|
0.80
|
38
|
Fibrocytes mediate intimal hyperplasia post-vascular injury and are regulated by two tissue factor-dependent mechanisms.
|
J Thromb Haemost
|
2013
|
0.78
|
39
|
Identification of two novel mutations in non-Jewish factor XI deficiency.
|
Br J Haematol
|
1995
|
0.78
|
40
|
Six point mutations that cause factor XI deficiency.
|
Blood
|
1995
|
0.78
|
41
|
Analysis of the consequences of premature termination codons within factor VIII coding sequences.
|
J Thromb Haemost
|
2003
|
0.77
|
42
|
Factor VIIShinjo: a dysfunctional factor VII variant homozygous for the substitution Gln for Arg at position 79.
|
Haemostasis
|
1995
|
0.77
|
43
|
Conjunctival retraction suture for fornix adjustable strabismus surgery.
|
Arch Ophthalmol
|
1991
|
0.77
|
44
|
Expression of hirudin fusion proteins in mammalian cells: a strategy for prevention of intravascular thrombosis.
|
Circulation
|
1998
|
0.77
|
45
|
Haemophilia A diagnosis by automated fluorescent DNA detection of ten factor VIII intron 13 dinucleotide repeat alleles.
|
Blood Coagul Fibrinolysis
|
1994
|
0.77
|
46
|
Human thrombin and FXa mediate porcine endothelial cell activation; modulation by expression of TFPI-CD4 and hirudin-CD4 fusion proteins.
|
Xenotransplantation
|
2001
|
0.76
|
47
|
Characterization of a recent retroposon insertion on mouse chromosome 2 and localization of the cognate parental gene to chromosome 11.
|
Mamm Genome
|
1998
|
0.75
|
48
|
Molecular Analysis in Factor XI Deficiency.
|
Methods Mol Med
|
1999
|
0.75
|
49
|
Stable recombinant expression and characterization of the two haemophilic factor VIII variants C329S (CRM(-)) and G1948D (CRM(r)).
|
Br J Haematol
|
2001
|
0.75
|
50
|
Molecular genetic analysis of factor XI deficiency: identification of five novel gene alterations and the origin of type II mutation in Portuguese families.
|
Thromb Haemost
|
2000
|
0.75
|
51
|
Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function.
|
J Biol Chem
|
1998
|
0.75
|
52
|
Molecular cloning of laminin.
|
Methods Enzymol
|
1987
|
0.75
|